PEMASON PHARMACEUTICALS LIMITED

What PEMASON PHARMACEUTICALS LIMITED does

PEMASON PHARMACEUTICALS LIMITED is a privately held Nigerian pharmaceutical company incorporated in 1997 and headquartered in Okota, Lagos. The company imports, registers, and markets a portfolio of more than 70 NAFDAC-registered pharmaceutical products across multiple therapeutic categories — including anti-malarials (artemether/lumefantrine combinations, quinine injections), anti-hypertensives (enalapril, amlodipine, lisinopril, nifedipine), antibiotics (ceftriaxone, amoxicillin-clavulanate, cefuroxime, gentamicin, spectinomycin), anti-inflammatory agents (dexamethasone, diclofenac, piroxicam), anti-spasmodics, H2 receptor antagonists, anti-platelet agents, supplements, and topical dermatological creams. Products are sourced from international manufacturing partners in Israel (Dexcel Pharma via Perth Pharmaceuticals), India (Medicef Pharma, Associated Biotech), and China (CSPC Pharmaceutical Group) and distributed across nine Nigerian states — Kano, Lagos, Edo, Abuja, Ogun, Enugu, Anambra, Osun, and Akwa-Ibom — through a field sales force that details physicians and serves pharmacies, hospitals, and clinics.

The company's revenue model is the marketing and distribution of finished pharmaceutical products sourced from third-party manufacturers; it does not operate its own manufacturing facilities, instead leveraging exclusive marketing agreements with its international partners. Its go-to-market is sales-led: field sales representatives report to a marketing manager and directors, conduct presentations to prospects, liaise with doctors to promote products, and maintain CRM-tracked pipelines. Pricing is not publicly disclosed and operates on a Request a Quote basis. Customer segments include government healthcare procurement (Kano State Government, Lagos State Ministry of Health), distribution partners (Alpha Pharma), and the long tail of Nigerian pharmacies, hospitals, and clinics. The company operates within a group structure alongside sister companies Future Compliant Ltd. (sole West African agent for A.Meshi Industries) and Green Hope Health Care Limited (associated with Medicef and Associated Biotech manufacturing partnerships), all under founding family (Osele) ownership.

The company's value proposition centers on providing NAFDAC-registered, internationally manufactured generic medicines across therapeutic categories prevalent in Nigeria — malaria, hypertension, bacterial infections, inflammatory conditions — at price points accessible to the Nigerian market. Marketing channels include a content-marketing blog, organic social media on Facebook and Instagram, and a product-catalog website. The company employs approximately 24 staff, has no external institutional investment disclosed, and has operated continuously since its 1997 incorporation.

Name

PEMASON PHARMACEUTICALS LIMITED

Legal name

PEMASON PHARMACEUTICALS LTD.

Website

https://pemason.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

PEMASON PHARMACEUTICALS LIMITED is a Nigerian pharmaceutical company founded in 1997 that imports, registers, and distributes over 70 NAFDAC-approved generic medicines across anti-malarial, anti-hypertensive, antibiotic, and other therapeutic categories to pharmacies, hospitals, clinics, and government health programs across nine Nigerian states.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Infectious Disease Specialty Pharmaceuticals (Non-vaccine) (HLAIACAM)

Keywords

• Pharmaceutical distribution
• Generic medicines
• Anti-malarial drugs
• Antibiotic products
• Pharmaceutical marketing

Headquarters

HQ city

Lagos

HQ country

Nigeria

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Import, registration, and marketing of pharmaceutical products sourced from Israel, India, and China, distributed across the Nigerian market through a network of sales representatives and healthcare providers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

PEMASON PHARMACEUTICALS LIMITED imports, registers, and markets a portfolio of over 70 branded and generic pharmaceutical products across multiple therapeutic categories including anti-malarials, antibiotics, anti-hypertensives, anti-inflammatory, anti-histamines, H2 receptor antagonists, anti-spasmodics, anti-emetics, anti-platelet agents, supplements, and topical creams. Products are sourced from manufacturing partners in Israel (Dexcel Pharma), India (Medicef Pharma, Associated Biotech), and China (CSPC Pharmaceutical Group) and distributed throughout Nigeria through a network of regional sales representatives.

Product overview

PEMASON PHARMACEUTICALS LIMITED is a Nigerian pharmaceutical company established in 1997 that markets and distributes a portfolio of over 70 pharmaceutical products. The company operates across multiple therapeutic categories including anti-malarials (PEMALIN, PENINE, PEMAMETRE, GRETHER), anti-hypertensives (ENALADEX, PEMALOD, PEMAPRIL, NIFEDIN DEXCEL), anti-biotics (PEMATRIAXONE, PEMACLAV, GREXIME, PEGENT), anti-inflammatory medications (PEMADEX, PENAC, PEMAXICAM), anti-spasmodics (PEMASON Hyoscine), H2 receptor antagonists (ZARIDEX), anti-platelet agents (MICROPIRIN), supplements (PEMACOMB, LOADANEW), and topical treatments (SKIPEM Cream). The company sources products from manufacturing partners in Israel (Dexcel Pharma), India (Medicef Pharma, Associated Biotech), and China (CSPC Pharmaceutical Group) and distributes them throughout Nigeria via a network of regional sales representatives.

Differentiator

Problem solved

Functional benefit

Brands

• Green Hope Health Care: Sister company manufacturing GRECLAV and GREXIME pharmaceutical series
• Future Compliant Ltd.

Products and services

• PEMALIN Injection (Artemether 80mg/ml)

Named customers3 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• Medicef Pharma (India)coreTechnology or Integration · 1 January 2010Global healthcare company established in 2010 with over $40 million USD in global sales per annum. Foremost Amoxycillin and Amoxycillin & Clavulanic Acid formulators. Manufactures the GRECLAV series in partnership with sister-company Green Hope Health Care Ltd.
• Dexcel Pharma (Israel)coreStrategic or Co-development PartnerIsrael's largest private pharmaceutical company, founded in 1968. Develops, manufactures, and markets value-added branded and generic pharmaceuticals. Pemason has an agreement with Perth Pharmaceuticals Limited (sole agent to Dexcel Limited, Israel) to market Dexcel products registered in Nigeria.
• Associated Biotech (India)coreTechnology or IntegrationWHO GMP-certified manufacturer serving more than 600 clients. Manufactures capsules, tablets & dry syrups in Cephalosporins, Non-Beta Lactum, Beta Lactum, and Nutraceuticals categories. Works with Green Hope Health Care Limited to manufacture the GREXIME series.
• CSPC Pharmaceutical Group Limited (China)coreStrategic or Co-development PartnerLeading pharmaceutical group in China. The 'CSPC' brand has been ranked among the 'Top 500 Most Valuable Brands in China' for more than ten consecutive years since 2004 (per World Brand Lab). Works with Pemason to manufacture high-quality products.
• Future Compliant Ltd.minorOthersSister company of Pemason Pharmaceuticals Limited and sole agent to A.Meshi Industries Ltd. (producers of Mon Platin products) in West Africa.
• Perth Pharmaceuticals LimitedcoreChannel Partner/ Reseller/ DistributorSole agent to Dexcel Limited, Israel. Agreement states that products registered by Perth Pharmaceuticals Ltd. in Nigeria will be marketed by Pemason Pharmaceuticals Limited.
• Green Hope Health Care LimitedminorOthersSister company that markets products from many countries. Associated with Medicef Pharma and Associated Biotech for manufacturing the GRECLAV and GREXIME product series.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Sanofi Nigeria: Multinational pharmaceutical company with Nigerian presence marketing a portfolio that includes anti-malarials and anti-infectives. Comparable in therapeutic overlap but operates as a global incumbent rather than a Nigerian-focused specialist.
• Pfizer Nigeria / Pfizer Inc. Global pharmaceutical incumbent with Nigerian distribution of anti-infectives and cardiovasculars. Overlaps with Pemason in selected prescription categories but competes from a multinational, branded-innovator position.
• GlaxoSmithKline Consumer Nigeria Plc (Haleon): Multinational pharmaceutical and consumer health company with Nigerian operations across multiple therapeutic areas. Overlaps with Pemason in selected prescription categories but operates at vastly larger scale and brand recognition.

Direct peers

• Emzor Pharmaceutical Industries Limited: One of Nigeria's largest indigenous pharmaceutical manufacturers and marketers with a broad generics portfolio across anti-malarials, antibiotics, and analgesics. Closely comparable to Pemason in therapeutic focus (especially anti-malarials and antibiotics) and Nigerian market orientation, though at significantly larger scale.
• Fidson Healthcare Plc: Nigerian pharmaceutical manufacturer and marketer listed on the NGX with a multi-therapeutic generics portfolio including anti-infectives and cardiovasculars. Directly comparable to Pemason in product mix and Nigerian distribution model.
• Drugfield Pharmaceuticals Limited: Nigerian pharmaceutical manufacturer and marketer of generics across multiple therapeutic areas including anti-malarials and anti-infectives. Directly comparable to Pemason in target market and product categories.
• Neimeth International Pharmaceuticals Plc: Nigerian pharmaceutical manufacturer/marketer with a diversified generics portfolio including anti-malarials and antibiotics. Operates in the same therapeutic categories and channels as Pemason.
• May & Baker Nigeria Plc: Long-established Nigerian pharmaceutical company with manufacturing and a broad prescription generics portfolio across anti-infectives and chronic disease. Comparable therapeutic focus and Nigerian market positioning to Pemason.
• Chi Pharmaceuticals Limited: Nigerian pharmaceutical company producing and marketing generics including anti-malarials, antibiotics, and cardiovascular drugs. Closely comparable in product mix and Nigerian field-sales distribution model.
• Swiss Pharma Nigeria Limited: Nigerian pharmaceutical company marketing a broad generics portfolio including anti-malarials and antibiotics. Comparable in therapeutic focus and Nigerian distribution footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/pemasonpharmltd
• Facebookfacebook.com/Pemason-Pharmaceuticals-Limited-106233731368424
• Instagraminstagram.com/pemasonpharmltd
• LinkedInlinkedin.com/company/pemason-pharmaceuticals-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PEMASON PHARMACEUTICALS LIMITED